Skip to product information
1 of 5

MAAB New Zealand

MAAB LDL Dual Action Probiotics

MAAB LDL Dual Action Probiotics

Regular price $60.00
Regular price Sale price $60.00
Sale Sold out
Tax included. Shipping calculated at checkout.

What is MAAB LDL Dual Action Probiotics?

Probiotics + plant sterols and stanols

Naturally founded alternative to lower cholesterol and improve cardiovascular health.

MAAB® LDL Probiotics contains two active ingredients in a bi-layer tablet LPLDL® and plant sterols & stanols to deliver a unique dual action cholesterol reducing formula1,2. MAAB® LDL Probiotics combines two synergistic ingredients to support the reduction of both internal and dietary cholesterol levels1,2.

  • Advanced dual action cholesterol health formula1,2

  • Unique formula supports both dietary and internal cholesterol1,2

  • Contains clinically studied probiotic LPLDL® shown to reduce cholesterol2

  • Unique bi-layer tablet ensures delivery of ingredients in optimum condition for maximum results


Instruction for use:

Take two tablets orally per day with a glass of water, preferably after a main meal.

Do not exceed the recommended daily dosage. This product is suitable for long-term use.



Phytosterol, Bulking Agents: Cellulose, Calcium Carbonate, Lactobacillus plantarum LPLDL®, Cross-Linked Sodium Methyl Cellulose, Stearic Acid, Anticaking Agent: Silicone Dioxide, Polyvinylpyrrolidone, Magnesium Stearate, Colouring Agent.

Supplement Facts:


Serving size: 2 tablets

Servings per container: 20

Per Dose
Phytosterol 95% 926mg
Lactobacillus plantarum LPLDL® 4 x 109 CFU



Store in a cool dry place away from direct sunlight.

Keep out of reach from children.

Caution: Only suitable for adults.

Food supplements should not be used as a substitute for a varied diet and a healthy lifestyle.



LPLDL® was selected out of 4000 different bacteria strains!



1.EFSA Journal 2010;8(10):1813 – Plant sterols/stanols contribute to the maintenance of normal blood cholesterol levels.



Costabile A, Buttarazzi I, Kolida S, Quercia S, Baldini J, Swann JR, et al. (2017) An in vivo assessment of the cholesterol-lowering efficacy of Lactobacillus plantarum ECGC 13110402 in normal to mildly hypercholesterolaemic adults. PLoS ONE 12(12): e0187964.

Keleszade E, Kolida S and Costabile A (2022) The cholesterol lowering efficacy of Lactobacillus plantarum ECGC 13110402 in hypercholesterolemic adults: a double-blind, randomized, placebo controlled, pilot human intervention study. Journal of Functional Foods 89: 104939.

View full details